earnings
CT
NASDAQ · CTOR
Citius Oncology, Inc.
Healthcare · Drug Manufacturers - General
$0.78
Down-$0.01 (-1.86%)
Updated Aug 31, 2026, 3:24 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 96.04M
- P/E ratio
- -3.1
- Dividend yield
- 0.00%
- 52-week range
- $0.49 – $1.02
- Volume
- 21.7K
- Avg. volume
- 372.06K
Price performance
CTOR price history
1M range · 20 trading sessions · Daily adjusted prices
CTOR closed at $0.78 after 20 trading sessions, up 24.02% for the selected period.
- Last close
- $0.78
- Period change
- +24.02%
- Period low
- $0.63
- Period high
- $0.91
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $0.80 | $0.80 | $0.7538 | $0.7756 | 21.7K |
| Aug 27, 2026 | $0.8275 | $0.83 | $0.7903 | $0.7903 | 8.57K |
| Aug 26, 2026 | $0.7908 | $0.82 | $0.7516 | $0.7871 | 17.08K |
| Aug 25, 2026 | $0.705 | $0.818 | $0.705 | $0.8101 | 134.13K |
| Aug 24, 2026 | $0.759 | $0.76 | $0.7222 | $0.75 | 16.69K |
| Aug 21, 2026 | $0.721 | $0.7549 | $0.721 | $0.7438 | 13.46K |
| Aug 20, 2026 | $0.7524 | $0.7734 | $0.71 | $0.7591 | 52.09K |
| Aug 19, 2026 | $0.73 | $0.78 | $0.6801 | $0.7525 | 58.03K |
| Aug 18, 2026 | $0.7178 | $0.7178 | $0.6594 | $0.703 | 86.69K |
| Aug 17, 2026 | $0.735 | $0.7816 | $0.7003 | $0.74 | 274.96K |
| Aug 14, 2026 | $0.8268 | $0.935 | $0.8009 | $0.9098 | 297.25K |
| Aug 13, 2026 | $0.82 | $0.85 | $0.7851 | $0.8268 | 81.09K |
| Aug 12, 2026 | $0.7252 | $0.8142 | $0.7072 | $0.8115 | 59.33K |
| Aug 11, 2026 | $0.743 | $0.743 | $0.7064 | $0.73 | 23.8K |
| Aug 10, 2026 | $0.76 | $0.76 | $0.7163 | $0.7375 | 75.08K |
| Aug 7, 2026 | $0.789 | $0.789 | $0.7332 | $0.753 | 45.24K |
| Aug 6, 2026 | $0.795 | $0.795 | $0.71 | $0.76 | 179.38K |
| Aug 5, 2026 | $0.63 | $0.89 | $0.63 | $0.785 | 1.04M |
| Aug 4, 2026 | $0.6793 | $0.68 | $0.64 | $0.66 | 74.13K |
| Aug 3, 2026 | $0.64 | $0.68 | $0.5535 | $0.6254 | 95.07K |
Latest CTOR news
The latest Smart Investors Daily articles mentioning CTOR.
Stock researchCompany · Financials
Loading stock research…